Newsletter | April 18, 2025

04.18.25 -- What If The Trump Tariff Strategy Works?

SPONSOR

Take a tour of Nanoform's best-in-class nanodevelopment capabilities, setting new standards in innovation. Their highly specialized team excels in creating unique nanoparticles for both small and large molecule APIs. With 14 development lines for small molecules and 5 for large molecules, Nanoform offers unmatched scalability and precision. Leveraging cutting-edge technology, they produce nanoformed materials as small as 10 nanometers. Learn more

INDUSTRY INSIGHTS

Stick-Pack Benefits For Pharmaceuticals And Nutraceuticals

Explore the key advantages of stick-pack formats for pharmaceuticals and nutraceuticals, from enhanced product safety and cost-efficiency to improved compliance and marketability.

Highly Potent API Drug Product Development, Manufacturing Using Micronization

As demand grows, the need for advanced safety measures and reliable manufacturing technologies becomes critical, making it essential to partner with an experienced HPAPI manufacturer.

Outsourcing Stability Storage: A Cost-Effective And Quality-Driven Approach

Partnering with a leader in outsourced stability storage is revolutionizing the pharmaceutical and medical device industry by saving costs and resources, and ensuring product quality and compliance.

FEATURED EDITORIAL

What If The Trump Tariff Strategy Works?

Doom and gloom in the drug development supply chain. Predictions of disruption and displacement. The Trump tariff ploy will fail, and costs will skyrocket. But have you considered this “risk”? The tariff tantrum lowers export/import duties globally.

Small Molecule CDMOs: Recent Consolidation And Expansion Developments

As the small molecule CDMO landscape expands, it is still fragmented, driving both M&A and big capital projects to get ahead.

INDUSTRY INSIGHTS CONTINUED

Advanced Analytical Tools To De-Risk Pharmaceutical Development

Discover three tools that facilitate a successful journey from candidate compound to clinical triumph: solid form screening, PBPK modeling, and AI-enabled route scouting.

Formulating Spray Dried Dispersions Into Tablets

Gain valuable insight on transforming spray-dried dispersions into effective tablet formulations by reading through our interview with Dr. Ian Lafferty, Chief Technical Officer at Upperton.

The 5 Ws Of A Human Factors Strategy

A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.

How To Select An Optimal Chromatography Silica

When selecting a chromatography resin, it is important to consider particle size, pore size, surface chemistry, scale, and surface area to help optimize efficiency, selectivity, and quality.

SPONSOR

We know how tough it can be to find the right CDMO, especially when capacity is tight and timelines are critical. That's why we're bringing together 31 CDMOs for our Outsourced Pharma Capacity Update Partners Week — a chance to explore their latest capabilities and available capacity, all from the convenience of your screen. Learn more about our sessions grouped by modality to join us to find the right partner for your project.

SOLUTIONS

Solving Complex Formulation Challenges From Coast To Coast

We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.

Preclinical Services Supporting Product Development: Powder Micromeritics

Understanding the fine details of powder properties is crucial in the pharmaceutical industry, where the behavior of particulate matter can affect manufacturability and the efficacy of the final product.

SPONSOR

Discover how CDMOs can help you achieve and maintain CMC compliance throughout the drug development lifecycle. Outsourced Pharma Live will explore how to leverage CDMO expertise in process optimization, documentation, and regulatory submissions. Learn practical strategies to align your CMC goals with CDMO capabilities to accelerate development and ensure successful drug launches.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: